TY  JOUR
TI  USING OF DAPAGLIFLOZIN BY PATIENT WITH DIABETES MELLITUS TYPE 2   AND NON-ALCOHOLIC FATTY LIVER DISEASE
KW  
JO  Clinical Medicine and Pharmacology
AU  Prilepa, S.A.
AU  Medvedeva, E.V.
AU  Dail'nev, V.I.
AU  Makisheva, R.T.
PY  2017
IS  3
PB  LLC Information and publishing center Innovations and investments